Proficiency assessments are important elements in quality control for diagnostic laboratories. Traditionally, proficiency testing for polymerase chain reaction (PCR)-based assays has involved the use of clinical samples, samples ''spiked'' with live agents or DNA plasmids. Because of government regulations and biosecurity concerns, distribution of live high-consequence pathogens of livestock and poultry, such as avian influenza, is not possible, and DNA plasmids are not technically suitable for evaluating RNA virus detection. Therefore, a proficiency testing panel using whole avian influenza in a diluent containing a phenolic disinfectant that inactivates the virus while preserving the RNA for at least 8 weeks at Ϫ70 C was developed and used in a multicenter proficiency assessment for a type A influenza real-time reverse transcriptase (RT)-PCR test. The test, which was highly standardized, except for variation in the real-time RT-PCR equipment used, was shown to be highly reproducible by proficiency testing in 12 laboratories in the United States, Canada, and Hong Kong. Variation in cycle threshold values among 35 data sets and 490 samples was minimal (CV ϭ 5.19%), and sample identifications were highly accurate (96.7% correct identifications) regardless of real-time PCR instrumentation.
Real-time polymerase chain reaction (PCR) is a relatively new PCR-based technology that, because of its many advantages over the standard PCR format, is being developed and implemented for the detection of many disease-causing agents. 4 Recently, a real-time reverse transcriptase (RRT)-PCR test was developed for avian influenza virus (AIV), where the test first identifies the presence of any type A influenza virus in a clinical sample and subsequently identifies the hemagglutinin subtype in positive samples. 11 The test was validated and used during a recent outbreak of H7N2 influenza in commercial poultry in Virginia 1 and during recent AIV outbreaks in the Hong Kong Special Administrative Region (SAR) (T. Ellis, personal communication). The same type A influenza test is also being validated for swine influenza. 6 Proficiency assessments are an essential part of quality assurance for diagnostic laboratories and have been implemented for many assay types including PCR-based assays, [7] [8] [9] [13] [14] [15] which are classified as highcomplexity tests by the clinical laboratory improvement amendments (http://www.cms.hhs.gov/clia). In addition to determining if end users are performing a test properly, proficiency testing can be used to generate data to evaluate the reproducibility and variability of the target test.
Traditionally, proficiency testing for PCR and RT-PCR-based assays has been done using samples containing live or potentially infectious material. For From the Southeast Poultry Research Laboratory, USDA-ARS, Athens, GA 30605. 1 Corresponding Author: Erica Spackman, Southeast Poultry Research Laboratory, USDA-ARS, 934 College Station Road, Athens, GA 30605. many agriculturally important pathogens, particularly those classified as high-consequence pathogens (Office International des Epizooties list A and list B agents) such as highly pathogenic avian influenza, distribution of infectious material is not possible; therefore a noninfectious alternative that mimics clinical samples must be used.
Previously it has been reported that AIV is inactivated by a solution of 1% Environ, a a phenolic disinfectant, whereas the viral RNA remains detectable by RT-PCR. 12 To determine if this could be used as a noninfectious sample for proficiency testing, 10-fold dilutions of chorioallantoic fluid containing live AIV (final titers between 10 1 and 10 4 50% chicken embryo infectious doses per milliliter [EID 50 /ml]) were prepared in a solution of 1% Environ One-Stroke. a Three diluents, deionized, nuclease-free, sterile water (diH 2 O); brain-heart infusion broth (BHI); and phosphate-buffered saline (PBS), were compared for relative sample stability. The stability of the viral RNA was evaluated in each diluent at 4 temperatures: ambient/room temperature (19-22 C), 4 C, Ϫ20 C, and Ϫ70 C for 12 weeks. Every 4 weeks, RNA was extracted with a commercial silicon-binding column RNA extraction kit b and then tested by RRT-PCR for the presence of type A influenza. Real-time RT-PCR was performed with a commercial 1-step RT-PCR kit c in accordance with the standard operating procedure (SOP) previously reported for processing AIV clinical samples. 11 The real-time RT-PCR reactions were run on a Cepheid Smart Cycler d with the following cycling conditions: RT step: 50 C for 30 minutes, 95 C for 15 minutes; PCR stage: 40 cycles of 95 C for 1 second, 60 C for 20 seconds. A set of samples was processed and tested on the day the samples were made to determine the baseline results. Negative controls included a solution of 1% Environ a in each of the 3 diluents stored at each of the test temperatures and tested at each time point with the virus-containing samples. All negative control samples were negative at each testing point.
Both temperature and diluent affected sample stability. None of the diluents were stable for 4 weeks at room temperature or at Ϫ20 C (Table 1) . At 4 C, diH 2 O and PBS were stable for 4 weeks. The samples were most stable at Ϫ70 C when diH 2 O was used as the diluent. Importantly, although stability is defined as the ability to detect the virus in a sample, cycle threshold (Ct) values did increase by approximately 5 cycles for diH 2 O at Ϫ70 C over 12 weeks indicating some loss of RNA integrity. The stability testing was repeated up to 8 weeks for the conditions under which the samples were most stable, in diH 2 O at Ϫ70 C, yielding the same results as those of the first test (data not shown).
Two sets of proficiency panels consisting of 14 samples that contained either no virus or between 10 1 EID 50 and 10 6 EID 50 of AIV in a solution of 1% Environ a in diH 2 O were prepared and distributed to 11 veterinary diagnostics labs in the United States, Hong Kong SAR, and Canada. One panel was run blindly by each technician in a lab who would normally process AIV clinical samples. An additional 10 panels were tested blindly by 6 technicians in our laboratory. All participants were instructed to run the panel in accordance with the previously described SOP, which included an RNA extraction method, RRT-PCR reaction conditions, type A influenza primer and probe sequences, and recommended specific reagents for all steps. 11 In addition, personnel from 8 of the participating labs had received hands-on training from the US Department of Agriculture (USDA) with the protocol. Participating laboratories were asked to report any deviation from the supplied SOP, record Ct values, and return their results within 1 week of receipt of the samples. The results were used to evaluate the overall performance of the AIV RRT-PCR test, including accuracy and reproducibility among different end users.
A total of 490 samples were evaluated from 35 data sets from 12 laboratories, including our own. The recommended SOP was used without modification for 24 data sets from 9 labs for a total of 336 samples. Modification of the SOP was due only to the use of realtime PCR instrumentation other than the Smart Cycler d ( Table 2) . Other real-time PCR instrumentation included the Lightcycler (LC), e for which the assay conditions have been previously reported, 11 and the iCycler f and ABI 7900, g for which the conditions were optimized internally by individual laboratories. Table 2 ). Because Ct values in real-time PCR methods are relatively quantitative, these values can be compared as a measure of reproducibility; 4 cycles are equal to approximately 1 log 10 difference in initial template concentration. The SD of the Ct values of all samples detected by laboratories that followed the SOP was 1.34 cycles and the CV was 5.19%. The reproducibility remained constant across the dynamic range of the test; SDs did not vary relative to the original amount of virus in a sample.
Among the data sets produced with the Smart Cycler d that contained false-negative results, 7 of 8 falsenegative samples (from 4 data sets) were with samples containing the lowest titer of virus ( Table 3) , indicating that false negatives were primarily due to test sensitivity. False negatives from the remaining data set were not clearly related to concentration; however, the technician who produced this data set reported that the RNA extraction step was performed incorrectly.
Although limited, the data produced with the LC, e iCycler, f and ABI 7900 g also had a high level of accuracy; of 11 data sets from 3 labs, 9 data sets were 100% correct (overall, 95.4% of the samples were identified correctly). False negatives were all in panels run on the LC e without bovine serum albumin (BSA), which is necessary to prevent the reaction components from binding to the glass capillary tubes used in this instrument. Runs that included BSA resulted in 100% correct sample identifications, reinforcing the fact that instrument-specific optimization is required for maximum sensitivity and accuracy. Because of technical differences among the other instruments and low numbers of data sets, Ct values were not compared among non-Smart Cycler d data sets.
Results combined from all real-time RT-PCR instrumentation were very similar to those produced by the Smart Cycler d alone ( Table 2 ). Of 490 samples 472 (96.3%) were correctly identified, and 28 of 35 data sets (80%) identified all samples correctly. Most (10 of 18) false negatives were from samples with the lowest virus concentration. No false positives were reported by any laboratory.
Samples containing live virus have often been used for proficiency testing in medical diagnostic laboratories; 3,10,17 however, for AIV and other economically important pathogens of poultry and livestock, proficiency testing with infectious virus is not possible. Because of the economic importance of many of these agents, active surveillance with PCR-based methods has been implemented or proposed as elements of the control programs for these agents. Therefore, quality assurance of end users is essential to ensure that adequate levels of sensitivity are maintained. Furthermore, proficiency testing for many of these assays will be required by the USDA for laboratories participating in surveillance and diagnostics for these agents. There-fore, a noninfectious alternative proficiency sample is essential.
Proficiency samples comprising DNA plasmids or in vitro-transcribed RNA, although noninfectious, are not optimal because the nucleic acid extraction step cannot be accurately evaluated. Inactivated whole virus is an option as long as the inactivation method does not destroy the RNA or inhibit the PCR reaction. Also, during proficiency testing it is important that the test sample mimics a clinical sample as closely as possible to accurately evaluate the ability of a lab or individual to perform a given test. With the format described here, each sample is subjected to the same processing procedures as clinical samples, including RNA extraction, RRT-PCR, and results interpretation.
Stability is also a key factor in the suitability of a proficiency testing sample format to ensure accurate evaluation of participating laboratories. Several buffers and media may be used for AIV transport; therefore, it was necessary to determine which medium offered the best sample preservation. Avian influenza virus has previously been shown to be very stable in BHI, 2 which is the standard transport medium for AIV and AIV-suspect diagnostic samples, and PBS is a common buffer for biological samples. Interestingly the stabilizing properties of BHI and PBS are lost when mixed with a phenolic disinfectant.
Importantly, results from the proficiency testing itself, which used diH 2 O, were obtained between 3 and 10 weeks of the date on which the panel was prepared without any signs of sample degradation. This further indicates that neither different storage times nor effects of shipping (the samples were shipped in insulated boxes on cold packs) affected the samples adversely.
Although a previous report on proficiency testing for real-time PCR showed high consistency, 5 high reproducibility has not always been observed among standard type PCR-based diagnostics assays by proficiency testing. 7, 14, 17 The high level of standardization of this test, including hands-on training, is probably the primary reason for the high consistency observed in this study. Also very importantly, real-time PCR instrumentation did not affect accuracy as long as optimized conditions specific for each instrument were used. Finally, the proficiency sample format reported here may be applied to other enveloped viruses that will require routine RRT-PCR proficiency testing such as Newcastle disease virus, which also uses a highly standardized RRT-PCR assay. 16 Acknowledgements. We greatly appreciate the participation of all labs that were involved in producing this data. We would also like to thank Suzanne De-Blois, Scott Lee, and Janice Pedersen for technical and other assistance with this work. This work was supported by USDA/ARS CRIS project number 6612-32000-039-00D. Mention of trade names or commercial products in this manuscript is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the USDA.
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